Young Scholars Award Lecture: Intratubular Angiotensinogen in Hypertension and Kidney Diseases

American Journal of Hypertension

Volumn 19, Issue 5, 2006, Pages 541-550

  Kobori, Hiroyuki ^a   Ozawa, Yuri ^a   Suzaki, Yuki ^a   Prieto Carrasquero, Minolfa C ^a   Nishiyama, Akira ^a,b   Shoji, Tatsuya ^c   Cohen, Eric P ^d   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensinogen; diabetic nephropathy; hypertension; immunoglobulin A nephropathy; kidney; radiation nephropathy

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RENIN; RESERPINE;

ACADEMIC ACHIEVEMENT; DIABETIC NEPHROPATHY; DISEASE COURSE; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; UPREGULATION;

ANGIOTENSINOGEN; ANIMALS; BIOLOGICAL MARKERS; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY TUBULES; RENIN-ANGIOTENSIN SYSTEM;

EID: 33646109291     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.11.014     Document Type: Review

References (119)

1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
2. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N.H., Eberlein K.A., Godwin J., Qizilbash N., Taylor J.O., and Hennekens C.H. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiologic context. Lancet 335 (1990) 827-838
3. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 288 (2002) 2981-2997
4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). J Am Med Assoc 288 (2002) 2998-3007
5. Mitchell K.D., and Navar L.G. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension. Pathophysiology, Diagnosis and Management. 2nd ed. (1995), Raven Press, New York 1437-1450
6. Navar L.G., Mitchell K.D., Harrison-Bernard L.M., Kobori H., and Nishiyama A. Intrarenal angiotensin II levels in normal and hypertensive states. J Renin-Angiotensin-Aldosterone Syst 2 (2001) S176-S184
7. Navar L.G., Harrison-Bernard L.M., Nishiyama A., and Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39 (2002) 316-322
8. Navar L.G., Kobori H., and Prieto-Carrasquero M.C. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 5 (2003) 135-143
9. Ichihara A., Kobori H., Nishiyama A., and Navar L.G. Renal renin-angiotensin system. Contrib Nephrol 143 (2004) 117-130
10. Gould A.B., and Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5 (1971) 86-89
11. Brasier A.R., and Li J.L. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27 (1996) 465-475
12. Ding Y., Davisson R.L., Hardy D.O., Zhu L.J., Merrill D.C., Catterall J.F., and Sigmund C.D. The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272 (1997) 28142-28148
13. Kimura S., Mullins J.J., Bunnemann B., Metzger R., Hilgenfeldt U., Zimmermann F., Jacob H., Fuxe K., Ganten D., and Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11 (1992) 821-827
14. Fukamizu A., Sugimura K., Takimoto E., Sugiyama F., Seo M.S., Takahashi S., Hatae T., Kajiwara N., Yagami K., and Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268 (1993) 11617-11621
15. Bohlender J., Menard J., Ganten D., and Luft F.C. Angiotensinogen concentrations and renin clearance. implications for blood pressure regulation. Hypertension 35 (2000) 780-786
16. Smithies O. A mouse view of hypertension. Hypertension 30 (1997) 1318-1324
17. Smithies O., and Kim H.S. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 91 (1994) 3612-3615
18. Merrill D.C., Thompson M.W., Carney C.L., Granwehr B.P., Schlager G., Robillard J.E., and Sigmund C.D. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97 (1996) 1047-1055
19. Inoue I., Nakajima T., Williams C.S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig E.H., Sharma A.M., Hata A., Jeunemaitre X., and Lalouel J.M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99 (1997) 1786-1797
20. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., and Lalouel J.M. Molecular basis of human hypertension. role of angiotensinogen. Cell 71 (1992) 169-180
21. Ingelfinger J.R., Zuo W.M., Fon E.A., Ellison K.E., and Dzau V.J. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85 (1990) 417-423
22. Terada Y., Tomita K., Nonoguchi H., and Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43 (1993) 1251-1259
23. Richoux J.P., Cordonnier J.L., Bouhnik J., Clauser E., Corvol P., Menard J., and Grignon G. Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 233 (1983) 439-451
24. Darby I.A., Congiu M., Fernley R.T., Sernia C., and Coghlan J.P. Cellular and ultrastructural location of angiotensinogen in rat and sheep kidney. Kidney Int 46 (1994) 1557-1560
25. Darby I.A., and Sernia C. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res 281 (1995) 197-206
26. Kobori H., Harrison-Bernard L.M., and Navar L.G. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12 (2001) 431-439
27. Yanagawa N., Capparelli A.W., Jo O.D., Friedal A., Barrett J.D., and Eggena P. Production of angiotensinogen and renin-like activity by rabbit proximal tubular cells in culture. Kidney Int 39 (1991) 938-941
28. Moe O.W., Ujiie K., Star R.A., Miller R.T., Widell J., Alpern R.J., and Henrich W.L. Renin expression in renal proximal tubule. J Clin Invest 91 (1993) 774-779
29. Henrich W.L., McAllister E.A., Eskue A., Miller T., and Moe O.W. Renin regulation in cultured proximal tubular cells. Hypertension 27 (1996) 1337-1340
30. Leyssac P.P. Changes in single nephron renin release are mediated by tubular fluid flow rate. Kidney Int 30 (1986) 332-339
31. Sibony M., Gasc J.M., Soubrier F., Alhenc-Gelas F., and Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 21 (1993) 827-835
32. Schulz W.W., Hagler H.K., Buja L.M., and Erdos E.G. Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 59 (1988) 789-797
33. Casarini D.E., Boim M.A., Stella R.C., Krieger-Azzolini M.H., Krieger J.E., and Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 272 (1997) F405-F409
34. 2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension 33 (1999) 96-101
35. 2 receptor subtypes in the rat kidney. Am J Physiol 277 (1999) F437-F446
36. Bouby N., Hus-Citharel A., Marchetti J., Bankir L., Corvol P., and Llorens-Cortes C. Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol 8 (1997) 1658-1667
37. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 273 (1997) F170-F177
38. Clauser E., Gaillard I., Wei L., and Corvol P. Regulation of angiotensinogen gene. Am J Hypertens 2 (1989) 403-410
39. Tewksbury D. Angiotensinogen. In: Fray J.C.S. (Ed). The Endocrine System: Endocrine Regulation of Water and Electrolyte Balance: Handbook of Physiology. 1st ed. (2000), Oxford University Press, Oxford 59-80
40. Ingelfinger J.R., Schunkert H., Ellison K.E., Pivor M., Zuo W.M., Pratt R., and Dzau V.J. Intrarenal angiotensinogen. localization and regulation. Pediatr Nephrol 4 (1990) 424-428
41. Sechi L.A., Griffin C.A., Giacchetti G., Valentin J.P., Llorens-Cortes C., Corvol P., and Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28 (1996) 403-408
42. Singh I., Grams M., Wang W.H., Yang T., Killen P., Smart A., Schnermann J., and Briggs J.P. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am J Physiol 270 (1996) F1027-F1037
43. Ingelfinger J.R., Pratt R.E., Ellison K., and Dzau V.J. Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest 78 (1986) 1311-1315
44. Kobori H., Nishiyama A., Abe Y., and Navar L.G. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41 (2003) 592-597
45. Kobori H., and Nishiyama A. Effects of Tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun 315 (2004) 746-750
46. Navar L.G. The kidney in blood pressure regulation and development of hypertension. Med Clin North Am 81 (1997) 1165-1198
47. Dzau V.J., and Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift?. Circulation 89 (1994) 493-498
48. Schunkert H., Ingelfinger J.R., Jacob H., Jackson B., Bouyounes B., and Dzau V.J. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 263 (1992) E863-E869
49. Kobori H., Harrison-Bernard L.M., and Navar L.G. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37 (2001) 1329-1335
50. Kobori H., Harrison-Bernard L.M., and Navar L.G. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61 (2002) 579-585
51. Kobori H., Nishiyama A., Harrison-Bernard L.M., and Navar L.G. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41 (2003) 42-49
52. 1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43 (2004) 1126-1132
53. Vanegas V., Ferrebuz A., Quiroz Y., and Rodriguez-Iturbe B. Hypertension in Page (cellophane-wrapped) kidney is caused by interstitial nephritis. Kidney Int 68 (2005) 1161-1170
54. Hackenthal E., Paul M., Ganten D., and Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70 (1990) 1067-1116
55. Deschepper C.F., Mellon S.H., Cumin F., Baxter J.D., and Ganong W.F. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci USA 83 (1986) 7552-7556
56. Rohrwasser A., Morgan T., Dillon H.F., Zhao L., Callaway C.W., Hillas E., Zhang S., Cheng T., Inagami T., Ward K., Terreros D.A., and Lalouel J.M. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34 (1999) 1265-1274
57. Lantelme P., Rohrwasser A., Gociman B., Hillas E., Cheng T., Petty G., Thomas J., Xiao S., Ishigami T., Herrmann T., Terreros D.A., Ward K., and Lalouel J.M. Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 39 (2002) 1007-1014
58. Prieto-Carrasquero M.C., Harrison-Bernard L.M., Kobori H., Ozawa Y., Hering-Smith K.S., Hamm L.L., and Navar L.G. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44 (2004) 223-229
59. 1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 289 (2005) F632-F637
60. Peti-Peterdi J., Warnock D.G., and Bell P.D. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 13 (2002) 1131-1135
61. Komlosi P., Fuson A.L., Fintha A., Peti-Peterdi J., Rosivall L., Warnock D.G., and Bell P.D. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42 (2003) 195-199
62. Wang C.T., Chin S.Y., and Navar L.G. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 279 (2000) F319-F325
63. Lavoie J.L., Lake-Bruse K.D., and Sigmund C.D. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 286 (2004) F965-F971
64. Kamitani A., Rakugi H., Higaki J., Yi Z., Mikami H., Miki T., and Ogihara T. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in japanese. J Hum Hypertens 8 (1994) 521-524
65. Ishikawa K., Baba S., Katsuya T., Iwai N., Asai T., Fukuda M., Takiuchi S., Fu Y., Mannami T., Ogata J., Higaki J., and Ogihara T. T+31c polymorphism of angiotensinogen gene and essential hypertension. Hypertension 37 (2001) 281-285
66. Katsuya T., Ishikawa K., Sugimoto K., Rakugi H., and Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 26 (2003) 521-525
67. Haddy F.J., and Pamnani M.B. Role of dietary salt in hypertension. J Am Coll Nutr 14 (1995) 428-438
68. Luke R.G. Essential hypertension. a renal disease? A review and update of the evidence. Hypertension 21 (1993) 380-390
69. Weinberger M.H. Sodium sensitivity of blood pressure. Curr Opin Nephrol Hypertens 2 (1993) 935-939
70. Iwai J., Dahl L.K., and Knudsen K.D. Genetic influence on the renin-angiotensin system. low renin activities in hypertension-prone rats. Circ Res 32 (1973) 678-684
71. Sakata Y., Masuyama T., Yamamoto K., Doi R., Mano T., Kuzuya T., Miwa T., Takeda H., and Hori M. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats. different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 37 (2001) 293-299
72. Hayashida W., Kihara Y., Yasaka A., Inagaki K., Iwanaga Y., and Sasayama S. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. J Mol Cell Cardiol 33 (2001) 733-744
73. Kodama K., Adachi H., and Sonoda J. Beneficial effects of long-term enalapril treatment and low-salt intake on survival rate of Dahl salt-sensitive rats with established hypertension. J Pharmacol Exp Ther 283 (1997) 625-629
74. 1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol 274 (1998) R1797-R1806
75. Hayakawa H., Coffee K., and Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension. effects of antihypertensive therapy. Circulation 96 (1997) 2407-2413
76. Nishikimi T., Mori Y., Kobayashi N., Tadokoro K., Wang X., Akimoto K., Yoshihara F., Kangawa K., and Matsuoka H. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 39 (2002) 1077-1082
77. Rudnichi A., Safar M.E., Lajemi M., and Benetos A. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension. Am J Hypertens 17 (2004) 321-327
78. Nakajima T., Wooding S., Sakagami T., Emi M., Tokunaga K., Tamiya G., Ishigami T., Umemura S., Munkhbat B., Jin F., Guan-Jun J., Hayasaka I., Ishida T., Saitou N., Pavelka K., Lalouel J.M., Jorde L.B., and Inoue I. Natural selection and population history in the human angiotensinogen gene (AGT). 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 74 (2004) 898-916
79. Okamoto K., Tabei R., Fukushima M., Nosaka S., and Yamori Y. Further observations of the development of a strain of spontaneously hypertensive rats. Jpn Circ J 30 (1966) 703-716
80. Vincent M., Dupont J., and Sassard J. Plasma renin activity as a function of age in two new strains of spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 50 (1976) 103-107
81. Kuriyama S., Kawashima K., and Sokabe H. Plasma renin activity determined by two different methods in spontaneously hypertensive rats. Jpn Heart J 23 (1982) 587-592
82. Nakamura Y., Ono H., Zhou X., and Frohlich E.D. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-l-arginine methyl ester/spontaneously hypertensive rats. Hypertension 37 (2001) 1262-1267
83. Teng J., Fukuda N., Suzuki R., Takagi H., Ikeda Y., Tahira Y., and Kanmatsuse K. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats. different anti-proliferative effect to angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol 39 (2002) 161-171
84. 1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Am J Hypertens 16 (2003) 931-937
85. Kobori H., Ozawa Y., Suzaki Y., and Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16 (2005) 2073-2080
86. Joss N., Paterson K.R., Deighan C.J., Simpson K., and Boulton-Jones J.M. Diabetic nephropathy. how effective is treatment in clinical practice?. Q J Med 95 (2002) 41-49
87. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
88. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
89. Haneda M., Koya D., and Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy. activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 38 (2001) S178-S181
90. Kikkawa R., Koya D., and Haneda M. Progression of diabetic nephropathy. Am J Kidney Dis 41 (2003) S19-S21
91. Park J.Y., Ha S.W., and King G.L. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Peritoneal Dial Int 19 Suppl 2 (1999) S222-S227
92. Shah S.V. Light emission by isolated rat glomeruli in response to phorbol myristate acetate. J Lab Clin Med 98 (1981) 46-57
93. Miyanoshita A., Takahashi T., and Endou H. Inhibitory effect of cyclic AMP on phorbol ester-stimulated production of reactive oxygen metabolites in rat glomeruli. Biochem Biophys Res Commun 165 (1989) 519-525
94. Ha H., and Endou H. Lipid peroxidation in isolated rat nephron segments. Am J Physiol 263 (1992) F201-F207
95. Ha H., and Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 77 Suppl (2000) S19-S25
96. Kagami S., Border W.A., Miller D.E., and Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93 (1994) 2431-2437
97. Yamamoto T., Nakamura T., Noble N.A., Ruoslahti E., and Border W.A. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90 (1993) 1814-1818
98. Border W.A., and Noble N.A. Cytokines in kidney disease. the role of transforming growth factor-beta. Am J Kidney Dis 22 (1993) 105-113
99. Zhang S.L., Filep J.G., Hohman T.C., Tang S.S., Ingelfinger J.R., and Chan J.S. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 55 (1999) 454-464
100. Zhang S.L., Tang S.S., Chen X., Filep J.G., Ingelfinger J.R., and Chan J.S. High levels of glucose stimulate angiotensinogen gene expression via the p38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology 141 (2000) 4637-4646
101. Hsieh T.J., Zhang S.L., Filep J.G., Tang S.S., Ingelfinger J.R., and Chan J.S. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143 (2002) 2975-2985
102. Zhang S.L., To C., Chen X., Filep J.G., Tang S.S., Ingelfinger J.R., and Chan J.S. Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol 13 (2002) 302-312
103. Zhang S.L., Chen X., Hsieh T.J., Leclerc M., Henley N., Allidina A., Halle J.P., Brunette M.G., Filep J.G., Tang S.S., Ingelfinger J.R., and Chan J.S. Hyperglycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. J Endocrinol 172 (2002) 333-344
104. Zhang S.L., Chen X., Wei C.C., Filep J.G., Tang S.S., Ingelfinger J.R., and Chan J.S. Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. Endocrinology 143 (2002) 4627-4635
105. Hsieh T.J., Fustier P., Zhang S.L., Filep J.G., Tang S.S., Ingelfinger J.R., Fantus I.G., Hamet P., and Chan J.S. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 144 (2003) 4338-4349
106. Nagai Y., Yao L., Kobori H., Miyata K., Ozawa Y., Miyatake A., Shokoji T., Kimura S., Kiyomoto H., Kohno M., Abe Y., and Nishiyama A. Temporary angiotensin blockade at the prediabetic stage attenuates the development of type 2 diabetic nephropathy. J Am Soc Nephrol 16 (2005) 703-711
107. Suzaki Y., Kobori H., and Ozawa Y. Intrarenal angiotensinogen augmentation is precedent to diabetic nephropathy in Zucker diabetic fatty obese rats. J Am Soc Nephrol 16 (2005) 202A
108. Dillon J.J. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol 24 (2004) 218-224
109. Kobori H., Ozawa Y., Suzaki Y., and Shoji T. Enhanced intrarenal angiotensinogen in IgA nephropathy patients. J Am Soc Nephrol 16 (2005) 521A
110. Lai K.N., Chan L.Y., Tang S.C., Tsang A.W., Li F.F., Lam M.F., Lui S.L., and Leung J.C. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 66 (2004) 1403-1416
111. Chan L.Y., Leung J.C., Tang S.C., Choy C.B., and Lai K.N. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 16 (2005) 2306-2317
112. Moulder J.E., Fish B.L., and Cohen E.P. ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr Pharm Des 9 (2003) 737-749
113. Cohen E.P., Fish B.L., and Moulder J.E. The renin-angiotensin system in experimental radiation nephropathy. J Lab Clin Med 139 (2002) 251-257
114. Cohen E.P., Kobori H., Moulder J.E., Fish B.L., and Navar L.G. Intrarenal angiotensinogen in radiation nephropathy. (abstract). J Invest Med 53 (2005) S288
115. Suzaki Y, Kobori H, Ozawa Y, Navar LG: Quantification of human angiotensinogen by a novel sandwich ELISA (abstract). Hypertension (in press).
116. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
117. Nishiyama A., Fukui T., Fujisawa Y., Rahman M., Tian R.X., Kimura S., and Abe Y. Systemic and regional hemodynamic responses to Tempol in angiotensin II-infused hypertensive rats. Hypertension 37 (2001) 77-83
118. Rodriguez-Iturbe B., Vaziri N.D., Herrera-Acosta J., and Johnson R.J. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension. all for one and one for all. Am J Physiol Renal Physiol 286 (2004) F606-F616
119. Lantelme P., Rohrwasser A., Vincent M., Cheng T., Gardier S., Legedz L., Bricca G., Lalouel J.M., and Milon H. Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens 23 (2005) 785-792